0% found this document useful (0 votes)
21 views4 pages

NP WD19 EOM2-2 AbhiGupta 2

The document discusses the transformative impact of technology on the pharmaceutical industry, highlighting advancements such as augmented reality, personalized medicine, 3D printing, and body sensors. It emphasizes the need for pharmaceutical companies to adapt to these changes due to challenges like productivity decline and expiring patents. To thrive, companies must invest in market-driven medicines and develop innovative marketing and sales strategies.

Uploaded by

dg6699work
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
21 views4 pages

NP WD19 EOM2-2 AbhiGupta 2

The document discusses the transformative impact of technology on the pharmaceutical industry, highlighting advancements such as augmented reality, personalized medicine, 3D printing, and body sensors. It emphasizes the need for pharmaceutical companies to adapt to these changes due to challenges like productivity decline and expiring patents. To thrive, companies must invest in market-driven medicines and develop innovative marketing and sales strategies.

Uploaded by

dg6699work
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4

Ellis 1

Andrew Ellis

Organizational Management

Professor Tanya Rydell

March 22, 2021

Pharmaceutical Industry Outlook

Technology has transformed the pharmaceutical industry and will continue to do so in

surprising ways. Already pharmaceutical companies are working closely with technology

firms to produce medical devices and software that focus on prevention rather than

treatments of diseases and illnesses (Galvan 18).

This paper explores other changes on the horizon for the pharmaceutical industry.

Patients want access to augmented and virtual reality. Consumers respond well to

augmented and virtual reality technologies that provide information they are seeking

(Khan). Medical patients can use the technologies to see how a drug works in three

dimensions instead of reading a long list of warnings and indications. Lab workers can

safely monitor experiments with augmented reality equipment, bringing medicines to

market faster.

Personalized medicine means patients can receive customized therapy. Genomics is the

branch of molecular biology that deals with the structure, function, evolution, and

mapping of genomes. (A genome is a complete set of genes.) To keep pace with

advances in genomics, pharmaceuticals could provide personalized medical plans based

on patient genomes. The industry could start by providing customized background

This file created specifically for Abhi Gupta


Ellis 2

information about sensitivities to drugs and dosages, long an intractable problem for

medical professionals.

Using 3D printing can move medicines to market quickly. The first 3D-printed drug,

Spiritam, is a treatment for epilepsy (Howe). Because it dissolves quickly, patients can

metabolize it and receive the benefits of the treatment faster. The technology could also

give rise to custom-printed drugs, so that prescriptions become programs pharmacists

use to produce drugs on demand in the perfect dosage for the patient. 3D printing could

become a new method of drug manufacturing.

Body sensors give consumers the power of information. Sensors that monitor vital signs

are already being produced as separate medical devices or as apps to install on a phone

(Wagner). Combining this technology with artificial intelligence can reduce the length of

illnesses and save lives. People can provide accurate symptoms to medical professionals

and schedule office visits earlier than they would without the technology.

These improvements are exciting, but few pharmaceutical companies are giving them

the attention they deserve. However, because of expiring patents, declining drug prices,

and expanding competition, pharmaceutical companies are the position of having to

transform or fail.

The most significant challenge for the industry is productivity decline. Companies are

simply producing fewer medications, especially the blockbuster, breakthrough

pharmaceuticals that once fueled the industry. Companies have experimented with

various approaches to lost productivity, including restructuring, adaptive trials, and

This file created specifically for Abhi Gupta


Ellis 3

innovative management strategies. The answer most likely involves a holistic solution

that addresses research and development, process, strategy, and funding.

To be successful, companies will need to invest in developing medicines the market

wants to buy and adopt a more flexible approach to pricing. They should also develop

plans for marketing and selling specialist therapies, especially those that take advantage

of technology. Ultimately, companies must develop marketing and sales functions that

are fit for the future and knowledge-based commercial organizations.

This file created specifically for Abhi Gupta


Ellis 4

Works Cited

Galvan, Allison. "Big Pharma and Biotech: A Perfect Match." Biotechnology Today 6 December

2020: 18-20. Print.

Howe, Dana. "3D Printing for Everything." 3D News 6 May 2020: 10. Print.

Khan, Doug. Virtual Reality Makes a Difference in Medicine. 23 September 2020. Website. 4

March 2021.

Wagner, Dorothy. More than Fitness Monitors: Body Sensors Are the Future of Medicine. 17

January 2021. Website. 2 March 2021.

This file created specifically for Abhi Gupta

You might also like